Christina DiArcangelo: dedicated to revolutionising patient care
DiArcangelo entered into medical cannabis following a personal experience with a loved one.Â
DiArcangelo entered into medical cannabis following a personal experience with a loved one.Â
In this article, Christopher Tasker, CEO of Global Cannabinoid Solutions, discusses how science can help your cannabis business.
The development will give hope to cancer patients as current treatment options for cancer-related pain are largely ineffective.
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
Cleaver Leaves has announced it will be supporting The University of Missouri by providing CBD isolate at no cost. Clever
The compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor Mechoulam.Â
MGC Pharma is hoping to bring more surprises to the market in the next few years.
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
The partnership will help to accelerate and advance research for both cannabis and psychedelics.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.